<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04810013</url>
  </required_header>
  <id_info>
    <org_study_id>CAR_FN_01</org_study_id>
    <nct_id>NCT04810013</nct_id>
  </id_info>
  <brief_title>Noninvasive Measurement of the Cerebral Autoregulation in Neonates and Infants With Complex Congenital Heart Disease</brief_title>
  <official_title>Noninvasive Measurement of the Cerebral Autoregulation in Neonates and Infants With Complex Congenital Heart Disease After Cardiac Surgery With Cardiopulmonary Bypass at the Pediatric Intensive Care Unit (PICU)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Tuebingen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Tuebingen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Feasibility of non-invasive cerebral autoregulation measurement at the PICU and impact of&#xD;
      changes in oxygen supply&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cerebral protection is a major issue in the treatment of neonates and infants with complex&#xD;
      congenital heart disease, because most common long-term morbidities of newborn heart surgery&#xD;
      are related not to the heart, but instead to the cognitive challenges experienced by this&#xD;
      population. Disruption of cerebral autoregulation in the postoperative period may contribute&#xD;
      to brain injury in these patients. Blood pressure management, respirator management and red&#xD;
      blood cell transfusion management after cardiopulmonary bypass surgery using endpoints such&#xD;
      cerebral autoregulation monitoring might provide a method to optimize organ perfusion and&#xD;
      improve neurologic outcome from cardiac surgery in the vulnerable postoperative period.&#xD;
&#xD;
      Primary Objectives: Feasibility of non-invasive cerebral autoregulation measurement at the&#xD;
      PICU: Identification of the range of mean arterial blood pressure (MAP) with optimal&#xD;
      vasoreactivity (MAPOPT), indicating intact cerebral autoregulation.&#xD;
&#xD;
      Secondary Objectives: Impact of decreased oxygen delivery, increased cerebral oxygen&#xD;
      extraction, decreased cardiac output, arterial hypotension, severe hypoxemia and/or severe&#xD;
      anemia on cerebral autoregulation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Range of mean arterial blood pressure</measure>
    <time_frame>4within 8 hours after cardiac surgery at the PICU</time_frame>
    <description>Measurement of the range of mean arterial blood pressure (MAP) with optimal vasoreactivity (MAPOPT)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Detection of severe brain injury</measure>
    <time_frame>before surgery, 12 hours, 48 hours, 72 hours post surgery and before discharge</time_frame>
    <description>Detection of cerebral haemorrhage grade III or IV, cystic periventricular leukomalacia, cerebellar haemorrhage, post-haemorrhagic ventricular dilatation or cerebral atrophy) on routinely performed serial cranial ultrasound scans</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurological outcome measure</measure>
    <time_frame>at age of 2 years</time_frame>
    <description>Landmarks of development score (Grenzsteine der Entwicklung Score) aus (Monatsschr Kinderheilkd_2013 · 161:898-910_· DOI 10.1007/s00112-012-2751-0 © Springer-Verlag Berlin Heidelberg 2013 R._Michaelis_· R._Berger_· U._Nennstiel-Ratzel_· I._Krägeloh-Mann Validierte und teilvalidierte Grenzsteine der Entwicklung).&#xD;
The score uses dichotomous questions, that asks for a Yes/No response. The score consists of a total of 16 questions, the more questions answered yes, the better the outcome and vice versa. Minimum value is n=0 yes and n=16 no answers, maximum value is n=16 yes and n=0 no answers.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Influence of changed fractional cerebral oxygen extraction (cFTOE) on cerebral autoregulation</measure>
    <time_frame>within 8 hours after cardiac surgery at the PICU</time_frame>
    <description>Analysis of the influence of changed fractional cerebral oxygen extraction (cFTOE) on cerebral autoregulation.Association between cFTOE and cerebral autoregulation indices (COx and HVx).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Influence of changed arterial blood pressure on cerebral autoregulation</measure>
    <time_frame>within 8 hours after cardiac surgery at the PICU</time_frame>
    <description>Analysis of the influence of changed arterial blood pressure on cerebral autoregulation. Association between arterial blood pressure (mmHg) and cerebral autoregulation indices (COx and HVx).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Influence of changed arterial oxygen saturation on cerebral autoregulation</measure>
    <time_frame>within 8 hours after cardiac surgery at the PICU</time_frame>
    <description>Analysis of the influence of changed arterial oxygen saturation on cerebral autoregulation. Association between arterial SPO2 (%) and cerebral autoregulation indices (COx and HVx).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Influence of changed blood hemoglobin concentration on cerebral autoregulation</measure>
    <time_frame>within 8 hours after cardiac surgery at the PICU</time_frame>
    <description>4. Analysis of the influence of changed blood hemoglobin concentration on cerebral autoregulation. Association between arterial hemoglobin value (g/dL) and cerebral autoregulation indices (COx and HVx).</description>
  </secondary_outcome>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Complex Congenital Heart Disease</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>non-invasive measurement of cerebral autoregulation</intervention_name>
    <description>Non-invasive measurement of the cerebral autoregulation in the postoperative period in 80 neonates and infants with complex congenital heart disease undergoing cardiopulmonary bypass surgery. A continuous, moving Pearson's correlation coefficient will be calculated between the arterial pressure and near-infrared spectroscopy signals and displayed continuously during surgery using a laptop computer and the ICM+ software (Cambridge Enterprise).</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Newborns&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  term (37-42 weeks gestation) newborns&#xD;
&#xD;
          -  pre- or postnatally diagnosed critical congenital heard disease (CHD)&#xD;
&#xD;
          -  admitted to the pediatric cardiac intensive care unit at the Children's Hospital of&#xD;
             Tübingen&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  birth weight &lt;2 kg&#xD;
&#xD;
          -  history of neonatal depression (5-min APGAR&lt;5, cord blood pH&lt;7.0, sepsis, or birth&#xD;
             asphyxia)&#xD;
&#xD;
          -  perinatal seizures&#xD;
&#xD;
          -  evidence of end-organ injury&#xD;
&#xD;
          -  preoperative cardiac arrest&#xD;
&#xD;
          -  significant preoperative intracerebral hemorrhage such as grade 3 or 4&#xD;
             intraventricular hemorrhage.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>1 Month</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Felix Neunhoeffer</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Children's Hospital Tübingen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Felix Neunhoeffer</last_name>
    <phone>+49 7071 29868334</phone>
    <email>Felix.Neunhoeffer@med.uni-tuebingen.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Michael Hofbeck, Prof.</last_name>
    <phone>+49-7071 29-84751</phone>
    <email>michael.hofbeck@med.uni-tuebingen.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Univeristy Children's Hospital</name>
      <address>
        <city>Tübingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Felix Neunhoeffer, Dr</last_name>
      <phone>+49 7071 29868334</phone>
      <email>felix.neunhoeffer@med.uni-tuebingen.de</email>
    </contact>
    <contact_backup>
      <last_name>Michael Hofbeck, Prof</last_name>
      <phone>+49 7071 29-84751</phone>
      <email>michael.hofbeck@med.uni-tuebingen.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 25, 2021</study_first_submitted>
  <study_first_submitted_qc>March 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 22, 2021</study_first_posted>
  <last_update_submitted>March 17, 2021</last_update_submitted>
  <last_update_submitted_qc>March 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Heart Defects, Congenital</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

